Opening plenary: Where MIDD Stands in 2026 & What The Field Needs to Solve

9:00 am - Wednesday 18th November 2026

  • Reflecting on how MIDD has evolved from a specialist modelling discipline into a strategic framework that influences decisions across discovery, clinical development, regulatory interactions, and lifecycle management
  • Assessing the impact of recent regulatory developments, including the finalisation of ICH M15, and discussing what successful implementation looks like across industry, regulatory agencies, and development teams
  • Exploring how emerging technologies are expanding the scope of questions that MIDD can address while introducing new expectations around model credibility and validation

Speakers:

Co-Chair Pharmacometrics WG, Pharmaceutical Drugs Directorate
Health Canada